Open
X

Posts Tagged 'PCSK9 inhibitors'

Your Doctor Prescribed a Medicine, But Will You Get It?

Seth J. Baum, MD In 2013 Dr. Tom Frieden, Director of the CDC, judiciously proclaimed that “even one preventable death is one too many.” Just three years later we are.. read more

The Collapse of Modern Medicine – From Bedside to Phone Calls

by Seth J. Baum MD Intending no disrespect to true war veterans, I will tell you that the 1980s was our Vietnam. As medical residents in New York City, the.. read more

Accessing PCSK9 Inhibitors: An Ongoing Bottleneck for Patients and Their Doctors

by Seth J. Baum MD PCSK9 inhibitors are the most significant advance in the management of elevated cholesterol in the last 3 decades. These injectable medications are indisputably revolutionary: They.. read more

PCSK9 Inhibitors: Why Are They Under-Prescribed?

by Seth J. Baum, MD A recent article by Caroline Humer and Ransdell Pierson for Reuters reported on the unexpectedly paltry number of prescriptions for PCSK9 inhibitors, the revolutionary cholesterol.. read more

Caution: Economists, Not Doctors Might be Prescribing Your Medicine

Posted on September 17th, 2015 · Posted in cardiology, Events, FH, lipids, medication, News

by Seth J. Baum, MD It’s National Cholesterol Education Month and we have fittingly entered a new era in lipid management. We now know that elevated LDL cholesterol causes heart.. read more

PCSK9 Inhibitors, A Historic Change in Cardiovascular Care

Posted on July 27th, 2015 · Posted in cardiology, News

by Seth J. Baum, MD, FACC, FACPM, FAHA, FNLA Every generation or so, each medical discipline hopes to experience a revolution of monumental proportions. Statins, released in the 1980s, were.. read more

FDA Gives Premarket Approval for Modification of LDL Indications for Use of Lipoprotein Apheresis System

Posted on July 21st, 2015 · Posted in cardiology, News

by Seth J. Baum, MD, FACC, FACPM, FAHA, FNLA The FDA has granted premarket approval to Kaneka Pharma America’s application requesting approval for modification of the indications for use of.. read more